BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10919005)

  • 1. Surgical treatment and postoperative outcomes for middle and lower bile duct carcinoma in Japan--experience of a single institute.
    Suzuki M; Unno M; Oikawa M; Endo K; Katayose Y; Matsuno S
    Hepatogastroenterology; 2000; 47(33):650-7. PubMed ID: 10919005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
    Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
    Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
    Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of lymph node involvement in middle and distal bile duct cancer.
    Sasaki R; Takahashi M; Funato O; Nitta H; Murakami M; Kawamura H; Suto T; Kanno S; Saito K
    Surgery; 2001 Jun; 129(6):677-83. PubMed ID: 11391365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
    Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
    Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study for the surgical treatment on distal bile duct carcinoma].
    Yoshikawa T; Hirano H; Araida T; Adzuma T; Ota T; Takasaki K
    Nihon Geka Gakkai Zasshi; 1997 May; 98(5):501-4. PubMed ID: 9213316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of the gallbladder: an appraisal of surgical resection.
    Chijiiwa K; Tanaka M
    Surgery; 1994 Jun; 115(6):751-6. PubMed ID: 7910985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.
    Kawai M; Tani M; Kobayashi Y; Tsuji T; Tabuse K; Horiuchi T; Oka M; Yamaguchi K; Sakata Y; Shimomura T; Yamaue H
    Am J Surg; 2010 Apr; 199(4):447-52. PubMed ID: 19596119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up.
    Bahra M; Jacob D; Langrehr JM; Neumann UP; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2008; 15(5):501-7. PubMed ID: 18836804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
    Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
    Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
    Meriggi F; Gramigna P; Forni E
    Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan.
    Nagakawa T; Kayahara M; Ikeda S; Futakawa S; Kakita A; Kawarada H; Matsuno M; Takada T; Takasaki K; Tanimura H; Tashiro S; Yamaoka Y
    J Hepatobiliary Pancreat Surg; 2002; 9(5):569-75. PubMed ID: 12541042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for radical resection of middle and distal bile duct cancer.
    Nomura T; Tsuchiya Y; Nashimoto A; Yabusaki H; Takii Y; Nakagawa S; Sato N; Kanbayashi C; Tanaka O
    Hepatogastroenterology; 2009; 56(90):294-8. PubMed ID: 19579585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
    Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
    Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis by Cox Proportional Hazards Model on prognoses of patients with bile duct carcinoma after resection.
    He P; Shi J; Chen W; Wang Z
    Chin Med J (Engl); 2002 Oct; 115(10):1538-41. PubMed ID: 12490105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
    J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is major hepatectomy with pancreatoduodenectomy justified for advanced biliary malignancy?
    Miwa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Ogawa S; Soeda J; Miyagawa S
    J Hepatobiliary Pancreat Surg; 2007; 14(2):136-41. PubMed ID: 17384903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of central inferior (S4a+S5) hepatic subsegmentectomy and pancreatoduodenectomy combined with extended lymphadenectomy for gallbladder carcinoma with subserous or mild liver invasion (pT2-3) and nodal involvement: a preliminary report.
    Sasaki R; Takeda Y; Hoshikawa K; Takahashi M; Funato O; Nitta H; Murakami M; Kawamura H; Suto T; Yaegashi Y; Kanno S; Saito K
    Hepatogastroenterology; 2004; 51(55):215-8. PubMed ID: 15011867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.